Janux Therapeutics, Inc.

JANX·NASDAQ·$14.40Share Price as of 11/2·$878MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report06/23/26 8-KCurrent report06/12/26 8-KCurrent report05/07/26 8-KCurrent report04/28/26

Prospectuses and Registrations

S-8Registration of securities for employees02/26/26 S-8Registration of securities for employees02/27/25 424B5Prospectus supplement12/05/24 424B5Prospectus supplement12/03/24 S-3ASRAutomatic shelf registration05/08/24

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEFA14AAdditional proxy materials06/17/24

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/31/26 Form 4Insider transaction07/10/26 Form 4Insider transaction06/12/26 Form 4Insider transaction06/12/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/25/25 ARSAnnual report to shareholders04/29/24 ARSAnnual report to shareholders04/28/23 EFFECTRequest for effectiveness09/19/22